Keshuo Ding
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
-
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- MicroRNA in disease regulation 10
- Oncology 10
- HER2/EGFR in Cancer Research 4
- Cancer Cells and Metastasis 2
- Co-authors
- Sheng Hui Tan (15 shared papers)Tao Zhu (13 shared papers)Peter Edward Lobie (10 shared papers)Rui Qiang Li (3 shared papers)Zhengsheng Wu (11 shared papers)Pengxu Qian (7 shared papers)Weijie Zhang (5 shared papers)Xiangjun Kong (4 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Frontiers in Oncology (3 papers)FEBS Open Bio (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- ChinaSingaporeNew Zealand
In The Last Decade
Keshuo Ding
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Cancer Research 429
- Oncology 156
- Molecular Biology 323
- Hepatology 42
- Drug Discovery 1
Countries citing papers authored by Keshuo Ding
This map shows the geographic impact of Keshuo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keshuo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keshuo Ding more than expected).
Fields of papers citing papers by Keshuo Ding
This network shows the impact of papers produced by Keshuo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keshuo Ding. The network helps show where Keshuo Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Keshuo Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 99 | |
| 2 | 2011 | 92 | |
| 3 | 2018 | 83 | |
| 4 | 2015 | 79 | |
| 5 | 2015 | 78 | |
| 6 | 2016 | 63 | |
| 7 | 2021 | 48 | |
| 8 | 2018 | 41 | |
| 9 | 2023 | 41 | |
| 10 | 2016 | 37 | |
| 11 | 2017 | 36 | |
| 12 | 2017 | 35 | |
| 13 | 2018 | 34 | |
| 14 | 2014 | 30 | |
| 15 | 2018 | 30 | |
| 16 | 2019 | 29 | |
| 17 | 2014 | 27 | |
| 18 | 2017 | 24 | |
| 19 | 2021 | 21 | |
| 20 | 2024 | 20 |
About Keshuo Ding
Keshuo Ding is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), RNA Research and Splicing (5 papers), HER2/EGFR in Cancer Research (4 papers), Gastric Cancer Management and Outcomes (4 papers), Estrogen and related hormone effects (3 papers), Immune cells in cancer (2 papers), Cancer Cells and Metastasis (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Cancer Research (429 citations), Oncology (156 citations), Molecular Biology (323 citations), Hepatology (42 citations) and Drug Discovery (1 citation). Keshuo Ding has collaborated with scholars based in China, Singapore and New Zealand. Frequent co-authors include Sheng Hui Tan, Tao Zhu, Peter Edward Lobie, Rui Qiang Li, Zhengsheng Wu, Pengxu Qian, Weijie Zhang, Xiangjun Kong, Gaopeng Li and Xiao Zhang. Their work appears in journals such as Journal of Biological Chemistry, Frontiers in Oncology, FEBS Open Bio, Journal of Experimental & Clinical Cancer Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.